Literature DB >> 11772428

Protein kinase C-eta regulates resistance to UV- and gamma-irradiation-induced apoptosis in glioblastoma cells by preventing caspase-9 activation.

Isa M Hussaini1, Joan E Carpenter, Gerard T Redpath, Julianne J Sando, Mark E Shaffrey, Scott R Vandenberg.   

Abstract

Both increased cell proliferation and apoptosis play important roles in the malignant growth of glioblastomas. We have demonstrated recently that the differential expression of protein kinase C (PKC)-eta increases the proliferative capacity of glioblastoma cells in culture; however, specific functions for this novel PKC isozyme in the regulation of apoptosis in these tumors has not been defined. In the present study of several glioblastoma cell lines, we investigated the role of PKC-eta in preventing UV- and gamma-irradiation-induced apoptosis and in caspase-dependent signaling pathways that mediate cell death. Exposure to UV or gamma irradiation killed 80% to 100% of PKC-eta-deficient nonneoplastic human astrocytes and U-1242 MG cells, but had little effect on the PKC-eta-expressing U-251 MG and U-373 MG cells. PKC-eta appears to mediate resistance to irradiation specifically such that when PKC-eta was stably expressed in U-1242 MG cells, more than 80% of these cells developed resistance to irradiation-induced apoptosis. Reducing PKC-eta expression by transient and stable expression of antisense PKC-eta in wild-type U-251 MG cells results in increased sensitivity to UV irradiation in a fashion similar to U-1242 MG cells and nonneoplastic astrocytes. Irradiation of PKC-eta-deficient glioblastoma cells resulted in the activation of caspase-9 and caspase-3, cleavage of poly (ADP-ribose) polymerase (PARP), and a substantial increase in subdiploid DNA content that did not occur in PKC-eta-expressing tumor cells. A specific inhibitor (Ac-DEVD-CHO) of caspase-3 blocked apoptosis in PKC-eta-deficient U-1242 MG cells. The data demonstrate that resistance to UV and gamma irradiation in glioblastoma cell lines is modified significantly by PKC-eta expression and that PKC-eta appears to block the apoptotic cascade at caspase-9 activation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11772428      PMCID: PMC1920632          DOI: 10.1093/neuonc/4.1.9

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  8 in total

1.  Protein kinase D2 is a novel regulator of glioblastoma growth and tumor formation.

Authors:  Ninel Azoitei; Alexander Kleger; Nina Schoo; Dietmar Rudolf Thal; Cornelia Brunner; Ganesh Varma Pusapati; Alina Filatova; Felicitas Genze; Peter Möller; Til Acker; Rainer Kuefer; Johan Van Lint; Heinrich Baust; Guido Adler; Thomas Seufferlein
Journal:  Neuro Oncol       Date:  2011-07       Impact factor: 12.300

2.  Novel regulation of protein kinase C-η.

Authors:  Deepanwita Pal; Shalini Persaud Outram; Alakananda Basu
Journal:  Biochem Biophys Res Commun       Date:  2012-08-07       Impact factor: 3.575

3.  Human DNA polymerase eta activity and translocation is regulated by phosphorylation.

Authors:  Yih-Wen Chen; James E Cleaver; Zafer Hatahet; Richard E Honkanen; Jang-Yang Chang; Yun Yen; Kai-Ming Chou
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-22       Impact factor: 11.205

4.  Upregulation of PKCη by PKCε and PDK1 involves two distinct mechanisms and promotes breast cancer cell survival.

Authors:  Deepanwita Pal; Shalini Persaud Outram; Alakananda Basu
Journal:  Biochim Biophys Acta       Date:  2013-04-04

5.  In vivo efficacy of a novel histone deacetylase inhibitor in combination with radiation for the treatment of gliomas.

Authors:  Michal Entin-Meer; Xiaodong Yang; Scott R VandenBerg; Kathleen R Lamborn; Abraham Nudelman; Ada Rephaeli; Daphne Adele Haas-Kogan
Journal:  Neuro Oncol       Date:  2007-03-08       Impact factor: 12.300

6.  PKCzeta protects against UV-C-induced apoptosis by inhibiting acid sphingomyelinase-dependent ceramide production.

Authors:  Alexandra Charruyer; Christine Jean; Audrey Colomba; Jean-Pierre Jaffrézou; Anne Quillet-Mary; Guy Laurent; Christine Bezombes
Journal:  Biochem J       Date:  2007-07-01       Impact factor: 3.857

7.  Unraveling the hidden role of a uORF-encoded peptide as a kinase inhibitor of PKCs.

Authors:  Divya Ram Jayaram; Sigal Frost; Chanan Argov; Vijayasteltar Belsamma Liju; Nikhil Ponnoor Anto; Amitha Muraleedharan; Assaf Ben-Ari; Rose Sinay; Ilan Smoly; Ofra Novoplansky; Noah Isakov; Debra Toiber; Chen Keasar; Moshe Elkabets; Esti Yeger-Lotem; Etta Livneh
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-30       Impact factor: 11.205

8.  Opioid receptor activation triggering downregulation of cAMP improves effectiveness of anti-cancer drugs in treatment of glioblastoma.

Authors:  Claudia Friesen; Inis Hormann; Mareike Roscher; Iduna Fichtner; Andreas Alt; Ralf Hilger; Klaus-Michael Debatin; Erich Miltner
Journal:  Cell Cycle       Date:  2014-03-12       Impact factor: 4.534

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.